A SIMPLE KEY FOR ACTIVE PHARMACEUTICAL INGREDIENTS UNVEILED

In a similar 12 months the ITC also claimed on their endeavours toward the movement syntheses of two lead compounds claimed previously by AstraZeneca. The primary a single information the flow synthesis of the strong 5HT1B antagonist (28) that was assembled via a five stage ongoing synthesis including a SNAr reaction, heterogeneous hydrogenation, M